Depression

The association between psychiatric disorders, most notably depression and anxiety, and pain is well established. However, mental health professionals, and especially psychiatrists, are still often excluded from treating patients with pain.

Cannabis is a widely used drug of abuse in adolescents. With legalization of marijuana, adolescent cannabis use may increase substantially.

Neurotransmitters may enhance mood-boosting effectS of exercise, cigarette use abstinence efforts going up in smoke, and other recent findings are summarized here.

Recent findings may relieve some of the guilt that accompanies the consumption of chocolate, particularly during depressive episodes.

In a first-of-its-kind study, researchers from the Icahn School of Medicine at Mount Sinai, Montefiore Health System, and Albert Einstein College of Medicine are working together to examine the link between depression and asthma in older adults.

Utilizing our senses-sight, hearing, AND smell-during the patient interview can provide a comprehensive exam and assist in assessment and treatment.

Some patients can get more depressed on this antidepressant. This isn't about bipolar disorder or antidepressant-induced mania. It's about a metabolite. More in this podcast.

Moving toward a bio-psycho-sociocultural model of major depression.

Some patients get more depressed on this antidepressant, but that does not mean they have bipolar disorder.

Teen depression rises with screen time, potential new target for novel antidepressants, and more key findings here.

Doing a review of systems wasn’t “rocket science,” as they say-but it was a classic example of medical science and of why psychiatrists are physicians first.

This new FDA order now allows patients who need and want ECT, as well as practitioners who perform it, to breathe a sigh of relief.

She was only 21. After "it" happened, I held a lecture on depression. I mentioned her at the end as a tribute. I longed for closure. More in this Portrait of a Psychiatrist.

Pediatric pearls with a focus on depression.

A study aimed to find out if cognitive training exercises that can boost attentional control and working memory could also influence emotional functioning.

Psychiatry has finally crossed into a new paradigm in the treatment of TRD, bringing the glutamate system on board to join the modulation of the monoamine systems.

Outpatient treatment sees modest growth, outcome expectancy varies with treatment type and time, “next steps” proposed for depression remission-here’s a brief look at some of the latest findings.

Withdrawal and retreat are the counter-transference pitfalls in TRD.  It is often done to the tune of “this is as good as it gets.” Scratch that. A bonus podcast accompanies this piece.

The chronic and relapsing course of TBI-associated depression poses a challenge to the management of afflicted patients.

Suicide is a leading cause of global mortality in those aged 25 years or younger. How can we promote safe communication about suicide in the digital age?

These concise summaries highlight the latest findings and potential remedies.

Bupropion is one of the better tolerated antidepressants, but concerns about anxiety, insomnia, and seizures have dampened its popularity. In this podcast, we’ll see how well those concerns hold up to the evidence.

A layperson's perspective after deliberating on the meaning of suicide for decades after the loss of his wife.

A teaching moment never to be forgotten, little did the author know that this action on his patient's part would be the harbinger of an amazing career looking after physicians.

Is there a biomarker to predict response to treatment for depression? Take the quiz and learn more.